Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 89433 · Class III · American Natl. Red Cross-Greater Chesapeake & Potomac Region
Key facts
| Event ID | 89433 |
|---|---|
| Recall numbers | B-0206-2022 |
| Recalling firm | American Natl. Red Cross-Greater Chesapeake & Potomac Region |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Apheresis Red Blood Cells were distributed without a final visual check. |
| Initiation date | Dec 8, 2021 |
| Report date | Feb 9, 2022 |
| Termination date | Jan 31, 2022 |
| City | Baltimore |
| State | MD |
| Country | United States |
| FEI number | 1173011 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: